Abstinence Reinforcement Therapy (ART) for rural veterans: Methodology for an mHealth smoking cessation intervention

Contemporary Clinical Trials

Volumn 50, Issue , 2016, Pages 157-165

  Wilson, Sarah M ^a,b   Hair, Lauren P ^b   Hertzberg, Jeffrey S ^b   Kirby, Angela C ^a,b   Olsen, Maren K ^c   Lindquist, Jennifer H ^c   Maciejewski, Matthew L ^c   Beckham, Jean C ^a,b,d   Calhoun, Patrick S ^a,b,c,d  

^a Education and Clinical Center MIRECC   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c Center for Health Services Research in Primary Care   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trial; eHealth; Financial incentives; Mobile health = mHealth; Smoking cessation; Telehealth

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILE CONTINGENCY MANAGEMENT; PATIENT COUNSELING; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SMARTPHONE; SMOKING CESSATION; TELEMEDICINE; TELEPHONE COUNSELING; VETERAN; COGNITIVE THERAPY; ECONOMICS; GOVERNMENT; METHODOLOGY; PROCEDURES; RURAL POPULATION; UNITED STATES;

NICOTINE GUM;

COGNITIVE THERAPY; HUMANS; RESEARCH DESIGN; RURAL POPULATION; SMOKING CESSATION; TELEMEDICINE; TOBACCO USE CESSATION PRODUCTS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 84983060327     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2016.08.008     Document Type: Article

References (81)

1. [1] Mokdad, A., Marks, J., Stroup, D., Gerberding, J., Actual causes of death in the United States. JAMA 291 (2004), 1238–1245.
2. [2] Brown, D., Smoking prevalence among US veterans. J. Gen. Intern. Med. 25 (2010), 147–149.
3. [3] Hamlett-Berry, K., Davidson, J., Kivlahan, D.R., Matthews, M.H., Hendrickson, J.E., Almenoff, P.L., Evidence-based national initiatives to address tobacco use as a public health priority in the Veterans Health Administration. Mil. Med. 174 (2009), 29–34.
4. [4] Substance Abuse Mental Health Services Administration (SAMHSA), Results From the 2006 National Survey on Drug Use and Health: National Findings. 2007, US Office of Applied Studies, Rockville.
5. [5] Vander Weg, M.W., Tobacco use and exposure in rural areas: findings from the Behavioral Risk Factor Surveillance System. Addict. Behav. 36 (2001), 231–236.
6. [6] Roberts, M.E., Doogan, N.J., Kurti, A.N., Redner, R., Gaalema, D.E., Stanton, C.A., et al. Rural tobacco use across the United States: how rural and urban areas differ, broken down by census regions and divisions. Health & Place 39 (2016), 153–159.
7. [7] Weeks, W., Mahar, P., Wright, S., Utilization of VA and Medicare services by Medicare-eligible Veterans: the impact of additional access points in a rural setting. J. Healthc. Manag. 50 (2005), 95–106.
8. [8] Hynes, D., Koelling, K., Stroupe, K., Veterans access to and use of Medicare and Veterans Affairs health care. Med. Care 45 (2007), 214–223.
9. [9] Duffy, S.A., Kilbourne, A.M., Austin, K.L., Dalack, G.W., Woltmann, E.M., Waxmonsky, J., et al. Risk of smoking and receipt of cessation services among veterans with mental disorders. Psychiatr. Serv. 63 (2012), 325–332.
10. [10] Fiore, M.C., Bailey, W.C., Cohen, S.J., Dorfman, S.F., Goldstein, M.G., Gritz, E.R., Treating Tobacco Use and Dependence: Clinical Practice Guideline. 2000, U.S. Department of Health and Human Service Public Health Service, Rockville, MD.
11. [11] Department of Veterans Affairs, Smoking and Tobacco Use Cessation Report. 2010, Veterans Health Administration, Washington, D.C.
12. [12] Thompson, R.S., Michnich, M.E., Friedlander, L., Gilson, B., Grothaus, L.C., Storer, B., Effectiveness of smoking cessation interventions integrated into primary care practice. Med. Care, 62-76, 1988.
13. [13] Hutcheson, T.D., Greiner, K.A., Ellerbeck, E.F., Jeffries, S.K., Mussulman, L.M., Casey, G.N., Understanding smoking cessation in rural communities. J. Rural. Health 24 (2008), 116–124.
14. [14] Cunningham, C.L., Kaboli, P.J., Ono, S., Vander Weg, M.W., A qualitative evaluation of knowledge of and attitudes toward VA smoking cessation services. J. Smok. Cessat. 6 (2011), 152–158.
15. [15] Sherman, S.E., Farmer, M.M., Best practices in tobacco control: identifying effective strategies for improving quality within the Veterans Health Administration, Presented at VA in the Vanguard: Building on Success in Smoking Cessation, Sept 2004.
16. [16] Abrams, D.B., Orleans, C.T., Niaura, R.S., Goldstein, M.G., Prochaska, J.O., Velicer, W., Integrating individual and public health perspectives for treatment of tobacco dependence under managed health care: a combined stepped care and matching model. Ann. Behav. Med. 18 (1996), 290–304.
17. [17] Carlson, L.E., Lounsberry, J.J., Maciejewski, O., Wright, K., Collacutt, V., Taenzer, P., Telehealth-delivered group smoking cessation for rural and urban participants: feasibility and cessation rates. Addict. Behav. 37 (2012), 108–114.
18. [18] Song, F., Raftery, J., Aveyard, P., Hyde, C., Barton, P., Woolacott, N., Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med. Decis. Mak. 22 (2002), S26–S37.
19. [19] Northridge, M.E., Vallone, D., Xiao, H.J., Green, M., Blackwood, J.W., Kemper, S.E., et al. The importance of location for tobacco cessation: rural-urban disparities in quit success in underserved West Virginia counties. J. Rural. Health 24 (2008), 106–115.
20. [20] Roll, J., Higgins, S., Steingard, S., McGinley, M., Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp. Clin. Psychopharmacol. 6 (1998), 157–161.
21. [21] Prendergast, M., Podus, D., Finney, J., Greenwell, L., Roll, J., Contingency management for treatment of substance use disorder: a meta-analysis. Addiction, 101, 2006.
22. [22] Correia, C., Benson, T., The use of contingency management to reduce cigarette smoking among college students. Exp. Clin. Psychopharmacol. 14 (2006), 171–179.
23. [23] Dallery, J., Raiff, B.R., Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst. Use Misuse 46 (2011), 10–22.
24. [24] Stoops, W.W., Dallery, J., Fields, N.M., Nuzzo, P.A., Schoenberg, N.E., Martin, C.A., et al. An internet-based abstinence reinforcement smoking cessation intervention in rural smokers. Drug Alcohol Depend. 105 (2009), 56–62.
25. [25] Dallery, J., Raiff, B.R., Grabinski, M.J., Internet-based contingency management to promote smoking cessation: a randomized controlled study. J. Appl. Behav. Anal. 46 (2013), 750–764.
26. [26] Federal Communications Commission, Broadband Progress Report. 2016, Federal Communications Commission, Washington, D.C., 2016.
27. [27] Perrin, A., Duggan, M., Americans' Internet Access: 2000–2015. 2015, Pew Research Center.
28. [28] Mantzari, E., Vogt, F., Shemilt, I., Wei, Y., Higgins, J.P.T., Marteau, T.M., Personal financial incentives for changing habitual health-related behaviors: a systematic review and meta-analysis. Prev. Med. 75 (2015), 75–85.
29. [29] Whittaker, R., McRobbie, H., Bullen, C., Borland, R., Rodgers, A., Gu, Y., Mobile phone-based interventions for smoking cessation. The Cochrane Library, 2012.
30. [30] Hertzberg, J.S., Carpenter, V.L., Kirby, A.C., Calhoun, P.S., Moore, S.D., Dennis, M.F., et al. Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder. Nicotine Tob. Res. 15 (2013), 1934–1938.
31. [31] Alterman, A.I., Gariti, P., Cook, T.G., Cnaan, A., Nicodermal patch adherence and its correlates. Drug Alcohol Depend. 53 (1999), 159–165.
32. [32] Balmford, J., Borland, R., Hammond, D., Cummings, K.M., Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob. Res. 13 (2011), 94–102.
33. [33] Bastian, L.A., Fish, L.J., Gierisch, J.M., Rohrer, L.D., Stechuchak, K.M., Grambow, S.C., Comparative effectiveness trial of family supported smoking cessation intervention versus standard telephone counseling for chronically ill veterans using proactive recruitment. Comp. Eff. Res. 2 (2012), 45–56.
34. [34] Cooper, T.V., DeBon, M.W., Stockton, M., Klesges, R.C., Steenbergh, T.A., Sherrill-Mittleman, D., et al. Correlates of adherence with transdermal nicotine. Addict. Behav. 29 (2004), 1565–1578.
35. [35] Radloff, L.S., The CES-D scale a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977), 385–401.
36. [36] Bush, K., Kivlahan, D.R., McDonell, M.B., Fihn, S.D., Bradley, K.A., The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch. Intern. Med. 158 (1998), 1789–1795.
37. [37] Prins, A., Ouimette, P., Kimerling, R., Cameron, R.P., Hugelshofer, D.S., Shaw-Hegwer, J., et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Prim. Care Psychiatr. 9 (2003), 9–14.
38. [38] National Institute of Standards and Technology, Federal Information Processing Standards Publication 140-2. Washington, D.C. 2001.
39. [39] Javors, M.A., Hatch, J.P., Lamb, R.J., Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction 100 (2005), 159–167.
40. [40] Heil, S., Higgins, S., Berstein, I., Solomon, L., Rogers, R., Thomas, C., et al. Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women. Addiction 103 (2008), 1009–1018.
41. [41] Carpenter, V.L., Hertzberg, J.S., Kirby, A.C., Calhoun, P.S., Moore, S.D., Dennis, M.F., et al. Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans. J. Clin. Psychiatry 76 (2015), 959–964.
42. [42] McFall, M., Saxon, A., Malte, C., Chow, B., Bailey, S., Baker, D., et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. JAMA 304 (2010), 2485–2493.
43. [43] Brown, R., Intensive behavioral treatment. Abrams, D., Niaura, R., Brown, R., Emmons, K., Goldstein, M., Monti, P., (eds.) The Tobacco Dependence Treatment Handbook, 2003, Guilford, New York.
44. [44] Bandura, A., Social Foundations of Thought and Action: A Social Cognitive Theory. 1985, Englewood Cliffs, Prentice Hall, Inc.
45. [45] Miller, W., Rollnick, S., Motivational Interviewing: Preparing People to Change Addictive Behavior. 1991, Guilford Press, New York.
46. [46] Prochaska, J.O., DiClemente, C.C., Stages and processes of self-change in smoking: toward an integrative model of change. J. Consult. Clin. Psychol. 51 (1983), 390–395.
47. [47] Carroll, K.M., A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 57 (2000), 225–238.
48. [48] Bars, M.P., Banauch, G.I., Appel, D., Andreachi, M., Mouren, P., Kelly, K., et al. “Tobacco free with FDNY”: the New York City Fire Department World Trade Center tobacco cessation study. Chest 129 (2006), 979–987.
49. [49] Weathers, F.W., Litz, B.T., Herman, D.S., Huska, J.A., Keane, T.M., The PTSD Checklist (PCL): reliability, validity, and diagnostic utility, Presented at the Annual Convention of the International Society for Traumatic Stress Studies. San Antonio, 1993.
50. [50] Spitzer, R.L., Kroenke, K., Williams, J.B., Group, P.H.Q.P.C.S., Validation and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA 282 (1999), 1737–1744.
51. [51] Williams, R.B., Barefoot, J.C., Califf, R.M., et al. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA 267 (1992), 520–524.
52. [52] The EuroQol Group, EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 16 (1990), 199–208.
53. [53] Morin, C.M., Barlow, D.H., Insomnia: Psychological Assessment and Management. 1993, Guilford Press, New York.
54. [54] Krebs, E.E., Lorenz, K.A., Bair, M.J., Damush, T.M., Wu, J., Sutherland, J.M., et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J. Gen. Intern. Med. 24 (2009), 733–738.
55. [55] Pomerleau, C.S., Carton, S.M., Lutzke, M.L., Flessland, K.A., Pomerleau OF, Reliability of the Fagerström Tolerance Questionnaire and the Fagerström Test for Nicotine Dependence. Addict. Behav. 19 (1994), 33–39.
56. [56] Shadel, W.G., Mermelstein, R., Borrelli, B., Self-concept changes over time in cognitive-behavioral treatment for smoking cessation. Addict. Behav. 21 (1996), 659–663.
57. [57] Schnoll, R.A., Calvin, J., Malstrom, M., Rothman, R.L., Wang, H., Babb, J., et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann. Behav. Med. 25 (2003), 214–221.
58. [58] Hymowitz, N., Cummings, K.M., Hyland, A., Lynn, W.R., Pechacek, T.F., Hartwell, T.D., Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob. Control. 6 (1997), S57–S62.
59. [59] Crittenden, K., Manfredi, C., Lacey, L., Warnecke, R., Parsons, J., Measuring readiness and motivation to quit smoking among women in public health clinics. Addict. Behav. 19 (1994), 497–507.
60. [60] Shiffman, S., Balabanis, M.H., Paty, J.A., Engberg, J., Gwaltney, C.J., Liu, K., Dynamic effects of self-efficacy on smoking lapse and relapse. Health Psychol. 19 (2000), 315–323.
61. [61] Baer, J.S., Holt, C.S., Lichtenstein, E., Self-efficacy and smoking reexamined: construct validity and clinical utility. J. Consult. Clin. Psychol. 54 (1986), 846–852.
62. [62] Velicer, W.F., DiClemente, C.C., Rossi, J.S., Prochaska, J.O., Relapse situations and self-efficacy: an integrative model. Addict. Behav. 15 (1990), 271–283.
63. [63] McBride, C.M., Curry, S.J., Lando, H.A., Pirie, P.L., Grothaus, L.C., Nelson, J.C., Prevention of relapse in women who quit smoking during pregnancy. Am. J. Public Health 89 (1999), 706–711.
64. [64] Horvath, A.O., Luborsky, L., The role of the therapeutic alliance in psychotherapy. J. Consult. Clin. Psychol. 61 (1993), 561–573.
65. [65] Morisky, D.E., Ang, A., Krousel-Wood, M., Ward, H.J., Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. 10 (2008), 348–354.
66. [66] Murray, D.M., McBride, C., Lindquist, R., Belcher, J.D., Sensitivity and specificity of saliva thiocyanate and cotinine for cigarette smoking: a comparison of two collection methods. Addict. Behav. 16 (1991), 161–166.
67. [67] Lewis-Esquerre, J.M., Colby, S.M., Tevyaw, T.O.L., Eaton, C.A., Kahler, C.W., Monti, P.M., Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend. 79 (2005), 33–43.
68. [68] Mottillo, S., Filion, K.B., Bélisle, P., Joseph, L., Gervais, A., O'Loughlin, J., et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur. Heart J. 30 (2009), 718–730.
69. [69] Myung, S., McDonnell, D.D., Kazinets, G., Seo, H., Moskowitz, J.M., Effects of web- and computer-based smoking cessation programs: meta-analysis of randomized controlled trials. Arch. Intern. Med. 169 (2009), 929–937.
70. [70] Fiscella, K., Franks, P., Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 275 (1996), 1247–1251.
71. [71] Diggle, P.J., Liang, K.Y., Zeger, S.L., Analysis of Longitudinal Data. 1994, Oxford University Press, New York.
72. [72] Gold, M.R., Siegel, J.E., Russel, L.B., Weinstein, M.C., Cost-effectiveness in Health and Medicine. 1996, Oxford University Press, New York.
73. [73] Briggs, A.H., Sculpher, M., Claxton, K., Decision Modelling for Health Economic Evaluation. 2006, Oxford University Press, New York.
74. [74] Willan, A., Briggs, A.H., Statistical Analysis of Cost-effectiveness Data. 2006, John Wiley & Sons Ltd., West Sussex, England.
75. [75] Chmura Kraemer, H., Kiernan, M., Essex, M., Kupfer, D.J., How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol. 27 (2008), S101–S108.
76. [76] Collins, L.M., Schafer, J.L., Kam, C.-M., A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol. Methods 6 (2001), 330–351.
77. [77] Little, R.J., D'Agostino, R., Cohen, M.L., Dickersin, K., Emerson, S.S., Farrar, J.T., et al. The prevention and treatment of missing data in clinical trials. N. Engl. J. Med. 367 (2012), 1355–1360.
78. [78] Hedeker, D., Mermelstein, R.J., Demirtas, H., Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction 102 (2007), 1564–1573.
79. [79] Anderson, M., Technology Device Ownership: 2015. 2015, Pew Research Center.
80. [80] Scarsella, A., Stofega, W., Worldwide Smartphone Forecast, 2016–2020. 2016, International Data Corporation.
81. [81] Department of Veterans Affairs, Office of Rural Health Annual Report: Thrive 2015. 2015, Veterans Health Administration, Washington, D.C.